MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Business / Industries / Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.
Old Articles: <Older 3721-3730 Newer>
The Motley Fool
May 17, 2007
Brian Lawler
MedImmune Gets the Thumbs-Up An advisory panel recommends expanded use for one of MedImmune's drugs. mark for My Articles 124 similar articles
The Motley Fool
May 16, 2007
Rich Duprey
Mylan's Costly Bid to Capture the Flag Its winning bid for a German Merck unit might be why it's falling behind in the generics game. Investors, take note. mark for My Articles 291 similar articles
The Motley Fool
May 16, 2007
Mike Havrilla
Nastech Nose Potential The small biotech reports the achievement of positive results for carbetocin nasal spray for the treatment of autism symptoms along with the completion of a $41 million stock offering in January. mark for My Articles 34 similar articles
The Motley Fool
May 16, 2007
Mike Havrilla
ZymoGenetics Is Poised to Stop Bleeding With shares of ZymoGenetics currently trading near three-year lows, now may be a good time to pick some up. mark for My Articles 123 similar articles
The Motley Fool
May 16, 2007
Brian Lawler
GPC's Next Cancer Drug? GPC Biotech prepares for its future as it awaits an FDA decision on its lead drug. Investors, take note. mark for My Articles 599 similar articles
The Motley Fool
May 15, 2007
Brian Lawler
King Fights for Its Empire King Pharmaceuticals announces another good quarter of financial results. Investors should expect more product acquisitions in the coming years. mark for My Articles 141 similar articles
The Motley Fool
May 15, 2007
Mike Havrilla
On the Threshold at Sonus The pharma is testing one drug that could be used to treat several types of cancer. Investors, take note. mark for My Articles 536 similar articles
The Motley Fool
May 15, 2007
Rich Duprey
Eisai Doles Out Tough Medicine The Japanese pharmaceutical company wins a patent infringement decision regarding its heartburn treatment. Investors, take note. mark for My Articles 303 similar articles
The Motley Fool
May 15, 2007
Mike Havrilla
A Heads-Up on TorreyPines The drugmaker's tezampanel for migraines shows promise after some trials. Investors, take note. mark for My Articles 141 similar articles
The Motley Fool
May 15, 2007
Mike Havrilla
Risky Bet OraSure Thing? The company strides forward to offer quick, less invasive methods of testing for disease and drugs. Investors, take note. mark for My Articles 17 similar articles
<Older 3721-3730 Newer>    Return to current articles.